Literature DB >> 11819394

A successful case of combined liver and kidney transplantation for autosomal dominant polycystic liver and kidney disease.

Xiao-Shun He, Jie-Fu Huang, Gui-Hua Chen, Ke-Li Zheng, Xiao-Ming Ye.   

Abstract

Entities:  

Year:  1999        PMID： 11819394      PMCID： PMC4688510          DOI： 10.3748/wjg.v5.i1.79

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  3 in total

1.  Evidence that the liver does not always protect the kidney from hyperacute rejection in combined liver-kidney transplantation across a positive lymphocyte crossmatch.

Authors:  A Eid; S B Moore; R H Wiesner; S R DeGoey; A Nielson; R A Krom
Journal:  Transplantation       Date:  1990-08       Impact factor: 4.939

2.  The role of combined liver/kidney transplantation in end-stage hepato-renal disease.

Authors:  A Shaked; M Thompson; A H Wilkinson; B Nuesse; G F el-Khoury; J T Rosenthal; G M Danovich; R W Busuttil
Journal:  Am Surg       Date:  1993-09       Impact factor: 0.688

3.  Primary hyperoxaluria (type I): attempted treatment by combined hepatic and renal transplantation.

Authors:  R W Watts; R Y Calne; R Williams; M A Mansell; N Veall; P Purkiss; K Rolles
Journal:  Q J Med       Date:  1985-10
  3 in total
  3 in total

Review 1.  ADPKD: clinical issues before and after renal transplantation.

Authors:  Piergiorgio Messa; Carlo Maria Alfieri; Emanuele Montanari; Mariano Ferraresso; Roberta Cerutti
Journal:  J Nephrol       Date:  2016-10-20       Impact factor: 3.902

2.  Supra Hepatic Inferior Vena Cava Thrombosis-Surgical Challenges.

Authors:  Senthil Muthuraman; Anand Ramamurthy; Mahesh Gopashetty; Cuddalore Sadasivam Vijayshankar; Anand Khakhar
Journal:  J Clin Diagn Res       Date:  2016-12-01

3.  Influence of intrauterine injection of rat fetal hepatocytes on rejection of rat liver transplantation.

Authors:  Yan-Ling Yang; Ke-Feng Dou; Kai-Zong Li
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.